Synthetica AD (BUL:SYN)

Regulus Therapeutics Ratios and Metrics

Market cap in millions BGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	228	210	156	150	145	133
Market Cap Growth	38.46%	34.62%	4.00%	3.73%	8.56%	3.26%
Enterprise Value	342	324	231	225	196	186
Last Close Price	76.00	70.00	52.00	50.00	48.20	44.40
PE Ratio	46.95	65.36	9.32	-	1877.92	127.59
PS Ratio	9.73	9.27	4.16	4.36	8.90	11.48
PB Ratio	6.48	5.98	4.91	6.46	5.43	6.42
P/TBV Ratio	6.81	6.28	5.18	7.65	6.72	7.62
P/FCF Ratio	38.04	44.54	3.05	34.30	45.91	58.01
P/OCF Ratio	35.66	41.04	3.04	32.92	38.27	34.56
EV/Sales Ratio	14.57	14.32	6.16	6.54	12.04	15.99
EV/EBITDA Ratio	-	136.62	34.88	33.80	5758.35	62.38
EV/EBIT Ratio	-	180.10	38.74	39.89	-	78.21
EV/FCF Ratio	57.00	68.76	4.52	51.42	62.15	80.83
Debt / Equity Ratio	3.41	3.40	2.99	5.04	1.54	2.36
Debt / EBITDA Ratio	31.36	50.33	14.30	17.55	1202.82	16.49
Debt / FCF Ratio	20.03	25.33	1.86	26.75	12.98	21.37
Asset Turnover	-	0.12	0.20	0.28	0.21	0.15
Inventory Turnover	-	5.68	11.73	17.77	5.82	2.04
Quick Ratio	0.12	0.15	0.21	0.40	0.17	0.15
Current Ratio	0.33	0.38	0.98	0.57	0.25	0.51
Return on Equity (ROE)	10.16%	9.66%	60.71%	-12.80%	-6.93%	5.25%
Return on Assets (ROA)	-	0.61%	2.01%	2.82%	-0.47%	1.92%
Return on Capital (ROIC)	1.42%	0.80%	2.79%	3.39%	-0.55%	2.21%
Return on Capital Employed (ROCE)	5.30%	2.90%	5.40%	5.10%	-	4.30%
Earnings Yield	2.13%	1.53%	10.73%	-1.11%	0.05%	0.78%
FCF Yield	2.63%	2.25%	32.76%	2.92%	2.18%	1.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.